Eloxx Pharmaceuticals
Stock Forecast, Prediction & Price Target

Eloxx Pharmaceuticals Financial Estimates

Eloxx Pharmaceuticals Revenue Estimates

Eloxx Pharmaceuticals EBITDA Estimates

Eloxx Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2020 12/31/2021 12/31/2022 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-34.57M
 
N/A
$-66.72M
 
-92.98%
$-36.06M
 
45.95%
Avg: $-44.5M
Low: $-14.40M
High: $-14.40M
avg. -23.38%
Avg: $-17.41M
Low: $-17.41M
High: $-17.41M
avg. 60.86%
EBITDA
 
% change YoY
$-33.45M
 
N/A
$-65.05M
 
-94.44%
$-33.37M
 
48.69%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$34.47
 
N/A
-$38.15
 
-10.67%
-$16.65
 
56.35%
Avg: -$6.65
Low: -$6.65
High: -$6.65
avg. 60.06%
Avg: -$8.04
Low: -$8.04
High: -$8.04
avg. -20.90%
Operating Expenses
 
% change YoY
$29.43M
 
N/A
$66.01M
 
124.26%
$34.41M
 
-47.86%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Eloxx Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 18.73% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -14.40M, average is -44.5M and high is -14.40M.

What is Eloxx Pharmaceuticals stock revenue growth forecast?

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Eloxx Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 19.57% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$6.65, average is -$6.65 and high is $-6.65.